Publications of Institute of Radiooncology - OncoRay (from 2013)

263 Publications
Correction of Geometrical Effects of a Knife-Edge Slit Camera for Prompt Gamma-Based Range Verification in Proton Therapy
Petzoldt, J.; Janssens, G.; Nenoff, L.; Richter, C.; Smeets, J.

Competing risks in survival data analysis
Dutz, A.; Löck, S.

Heterogeneity of γH2AX foci increases in ex vivo biopsies relative to in vivo tumors
Rassamegevanon, T.; Löck, S.; Baumann, M.; Krause, M.; von Neubeck, C.

Molecular imaging using the theranostic agent 197(m)Hg: phantom measurements and Monte Carlo simulations
Freudenberg, R.ORC; Apolle, R.ORC; Walther, M.; Hartmann, H.; Kotzerke, J.

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer
de Jonga, E.; van Elmpt, W.; Rizzo, S.; Colarieti, A.; Spitaleri, G.; Leijenaar, R.; Jochems, A.; Hendriks, L.; Troost, E.; Reymen, B.; Dingemans, A.-M.; Lambin, P.

Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus
Lambrecht, M.; Eekers, D.; Alapetite, C.; Burnet, N.; Calugaru, V.; Coremans, I.; Fossati, P.; Høyer, M.; Langendijk, J.; Romero, A. M.; Paulsen, F.; Perpar, A.; Renard, L.; de Ruysscher, D.; Timmermann, B.; Vitek, P.; Weber, D.; van der Weide, H.; Whitfield, G.; Wiggenraad, R.; Roelofs, E.; Nyström, P. W.; Troost, E.

In vivo imaging in the oral cavity by endoscopic optical coherence tomography
Walther, J.; Schnabel, C.; Tetschke, F.; Rosenauer, T.; Golde, J.; Ebert, N.; Baumann, M.; Hannig, C.; Koch, E.

Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis
Niyazi, M.; Adeberg, S.; Kaul, D.; Boulesteix, A.; Bougatf, N.; Fleischmann, D.; Grün, A.; Krämer, A.; Rödel, C.; Eckert, F.; Paulsen, F.; Kessel, K.; Combs, S.; Oehlke, O.; Grosu, A.; Seidlitz, A.; Lattermann, A.; Krause, M.; Baumann, M.; Guberina, M.; Stuschke, M.; Budach, V.; Belka, C.; Debus, J.

Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours
Dutz, A.; Lühr, A.; Agolli, L.; Troost, E. G. C.; Krause, M.; Baumann, M.; Vermeren, X.; Geismar, D.; Schapira, E. F.; Bussière, M.; Daly, J. E.; Bussière, M. R.; Timmermann, B.; Shih, H. A.; Löck, S.

Keine Überlegenheit der Protonentherapie gegenüber der IMRT beim lokal fortgeschrittenen NSCLC
Dutz, A.; Troost, E. G. C.; Löck, S.

Union of light ion therapy centers in Europe (ULICE EC FP7) - Objectives and achievements of joint research activities
Pötter, R.; Balosso, J.; Baumann, M.; Bert, C.; Davies, J.; Enghardt, W.; Fossati, P.; Harris, S.; Jones, B.; Krämer, M.; Mayer, R.; Mock, U.; Pullia, M.; Schreiner, T.; Dosanjh, M.; Debus, J.; Orecchia, R.; Georg, D.

Radiobiological effects and proton RBE determined by wildtype zebrafish embryos
Szabo, E. R.; Brand, M.; Hans, S.; Hideghety, K.; Karsch, L.; Leßmann, E.; Pawelke, J.; Schürer, M.; Beyreuther, E.

Integrating a low-field open MR scanner with a static proton research beam line: proof of concept
Schellhammer, S. M.ORC; Hoffmann, A. L.; Gantz, S.; Smeets, J.; van der Kraaij, E.; Quets, S.; Pieck, S.; Karsch, L.; Pawelke, J.

Preclinical imaging for establishment and comparison of orthotopic Non-Small Cell Lung Carcinoma: In search for models reflecting clinical scenarios
Aktar, R.; Dietrich, A.; Tillner, F.; Kotb, S.; Löck, S.; Willers, H.; Baumann, M.; Krause, M.; Bütof, R.

Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)
Combs, S.; Niyazi, M.; Adeberg, S.; Bougatf, N.; Kaul, D.; Fleischmann, D.; Gruen, A.; Fokas, E.; Rodel, C.; Eckert, F.; Paulsen, F.; Oehlke, O.; Grosu, A.; Seidlitz, A.; Lattermann, A.; Krause, M.; Baumann, M.; Guberina, M.; Stuschke, M.; Budach, V.; Belka, C.; Debus, J.; Kessel, K.

Prostate cancer stem cells: current understanding
Skvortsov, S.; Skvortsova, I. I.; Tang, D. G.; Dubrovska, A.

Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy - Results of the randomized CHARTWEL trial
Hechtner, M.; Krause, M.; Konig, J.; Appold, S.; Hornemann, B.; Singer, S.; Baumann, M.

Cognitive deficits following brain tumor radiation therapy
Buthut, M.; Haussmann, R.; Seidlitz, A.; Krause, M.; Donix, M.

Reply to “Comment on Methodological accuracy of image-based electron density assessment using dual-energy computed tomography” [Med. Phys. 44, 2429-2437 (2017)]
Möhler, C.ORC; Wohlfahrt, P.ORC; Richter, C.; Greilich, S.ORC

Dose-guided patient positioning in proton radiotherapy using multicriteria-optimization
Kurz, C.; Süss, P.; Arnsmeyer, C.; Haehnle, J.; Teichert, K.; Landry, G.; Hofmaier, J.; Exner, F.; Hille, L.; Kamp, F.; Thieke, C.; Ganswindt, U.; Valentini, C.; Hölscher, T.; Troost, E.; Krause, M.; Belka, C.; Küfer, K.; Parodi, K.; Richter, C.

„Radiobiology of Proton Therapy“: results of an international expert workshop
Lühr, A.; von Neubeck, C.; Pawelke, J.; Seidlitz, A.; Peitzsch, C.; Bentzen, S.; Bortfeld, T.; Debus, J.; Deutsch, E.; Langendijk, J.; Löffler, J.; Mohan, R.; Scholz, M.; Sørensen, B.; Weber, D.; Baumann, M.; Krause, M.

Comparison of treatment planning strategies for intensity-modulated proton therapy with simultaneous integrated boost target for pancreatic cancer
Stefanowicz, S.; Stützer, K.; Zschaeck, S.; Jakobi, A.; Troost, E. G. C.ORC

Overview of research and therapy facilities for radiobiological experimental work in particle therapy. Report from the European Particle Therapy Network radiobiology group
Dosanjh, M.; Jones, B.; Pawelke, J.ORC; Pruschy, M.; Singers Sørensen, B.

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
Juratli, T. A.; Thiede, C.; Koerner, M. V. A.; Tummala, S. S.; Daubner, D.; Shankar, G. M.; Williams, E. A.; Martinez-Lage, M.; Soucek, S.; Robel, K.; Penson, T.; Krause, M.; Appold, S.; Meinhardt, M.; Pinzer, T.; Miller, J. J.; Krex, D.; Ely, H. A.; Silverman, I. M.; Christiansen, J.; Schackert, G.; Wakimoto, H.; Kirsch, M.; Brastianos, P. K.; Cahill, D. P.

An Image Reconstruction Framework and Camera Prototype Aimed for Compton Imaging for In-vivo Dosimetry of Therapeutic Ion Beams
Schoene, S.; Enghardt, W.; Fiedler, F.; Golnik, C.; Pausch, G.; Rohling, H.; Kormoll, T.

Detection Systems for Range Monitoring in Proton Therapy: Needs and Challenges
Pausch, G.; Berthold, J.; Enghardt, W.; Römer, K.; Straessner, A.; Wagner, A.; Werner, T.; Kögler, T.
  • Lecture (Conference)
    2018 Symposium on Radiation Measurements and Applications (SORMA XVII), 11.-14.06.2018, Ann Arbor, MI, USA
  • Nuclear Instruments and Methods in Physics Research A (2018)
    Online First (2018) DOI: 10.1016/j.nima.2018.09.062

Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen,
Bailey, D. L.; Pichler, B. J.; Gückel, B.; Antoch, G.; Barthel, H.; Bhujwalla, Z. M.; Biskup, S.; Biswal, S.; Bitzer, M.; Boellaard, R.; Braren, R. F.; Brendle, C.; Brindle, K.; Chiti, A.; La Fougère, C.; Gillies, R.; Goh, V.; Goyen, M.; Hacker, M.; Heukamp, L.; Knudsen, G. M.; Krackhardt, A. M.; Law, I.; Morris, J. C.; Nikolaou, K.; Nuyts, J.; Ordonez, A. A.; Pantel, K.; Quick, H. H.; Riklund, K.; Sabri, O.; Sattler, B.; Troost, E.; Zaiss, M.; Zender, L.; Beyer, T.

Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments.
Krause, M.; Dubrovska, A.; Linge, A.; Baumann, M.

PORTAF–postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation–study protocol for a randomized controlled trial
Bütof, R.; Simon, M.; Löck, S.; Troost, E.; Appold, S.; Krause, M.; Baumann, M.

Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire.
Weber, D. C.; Abrunhosa-Branquinho, A.; Bolsi, A.; Kacperek, A.; Dendale, R.; Geismar, D.; Bachtiary, B.; Hall, A.; Heufelder, J.; Herfarth, K.; Debus, J.; Amichetti, M.; Krause, M.; Orecchia, R.; Vondracek, V.; Thariat, J.; Kajdrowicz, T.; Nilsson, K.; Grau, C.

Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR Pathway.
Wang, M.; Han, J.; Marcar, L.; Black, J.; Liu, Q.; Li, X.; Nagulapalli, K.; Sequist, L. V.; Mak, R. H.; Benes, C. H.; Hong, T. S.; Gurtner, K.; Krause, M.; Baumann, M.; Kang, J. X.; Whetstine, J. R.; Willers, H.

Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium
Stangl, S.; Tontcheva, N.; Sievert, W.; Shevtsov, M.; Niu, M.; Schmid, T.; Pigorsch, S.; Combs, S.; Haller, B.; Balermpas, P.; Rödel, F.; Rödel, C.; Fokas, E.; Krause, M.; Linge, A.; Lohaus, F.; Baumann, M.; Tinhofer, I.; Budach, V.; Stuschke, M.; Grosu, A.; Abdollahi, A.; Debus, J.; Belka, C.; Maihöfer, C.; Mönnich, D.; Zips, D.; Multhoff, G.

Tumor heterogeneity determined with a γH2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models
Rassamegevanon, T.; Löck, S.; Range, U.; Krause, M.; Baumann, M.; von Neubeck, C.

Development of a genetic sensor that eliminates p53 deficient cells
Mircetic, J.; Dietrich, A.; Paszkowski-Rogacz, M.; Krause, M.; Buchholz, F.

Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
Linge, A.; Schötz, U.; Löck, S.; Lohaus, F.; von Neubeck, C.; Gudziol, V.; Nowak, A.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Bunea, H.; Grosu, A.; Abdollahi, A.; Debus, J.; Ganswindt, U.; Lauber, K.; Pigorsch, S.; Combs, S.; Mönnich, D.; Zips, D.; Baretton, G.; Buchholz, F.; Krause, M.; Belka, C.; Baumann, M.

Stereotactic radiosurgery for brainstem metastases : In experienced hands a good treatment option with excellent risk-benefit ratio
Khademalhosseini, Z.; Khademolhosseini, M.; Kummer, B.; Krause, M.

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
De-Colle, C.; Mönnich, D.; Welz, S.; Boeke, S.; Sipos, B.; Fend, F.; Mauz, P.-S.; Tinhofer, I.; Budach, V.; Jawad, J. A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Grosu, A.-L.; Abdollahi, A.; Debus, J.; Bayer, C.; Belka, C.; Pigorsch, S.; Combs, S. E.; Lohaus, F.; Linge, A.; Krause, M.; Baumann, M.; Zips, D.; Menegakis, A.

The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Balermpas, P.; Rödel, F.; Krause, M.; Linge, A.; Lohaus, F.; Baumann, M.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Gkika, E.; Grosu, A.-L.; Abdollahi, A.; Debus, J.; Stangl, S.; Ganswindt, U.; Belka, C.; Pigorsch, S.; Multhoff, G.; Combs, S. E.; Welz, S.; Zips, D.; Lim, S. Y.; Rödel, C.; Fokas, E.

Prompt gamma spectroscopy for range control with CeBr3.
Martins, P. M.; Bello, R. D.; Rinscheid, A.; Roemer, K.; Werner, T.; Enghardt, W.; Pausch, G.; Seco, J.

Prospective data registration and clinical trials for particle therapy in Europe
Langendijk, J.; Orrechhia, R.; Haustermans, K.; Zips, D.; Balosso, J.; Lievens, Y.; Weber, D.; Grau, C.; Troost, E.

Practice patterns of image guided particle therapy in Europe: a 2016 survey of the European Particle Therapy Network (EPTN)
Bolsi, A.; Peroni, M.; Amelio, D.; Dasu, A.; Stock, M.; Toma-Dasu, I.; Witt Nyström, P.; Hoffmann, A. L.

Research facility for radiobiological studies at the University Proton Therapy Dresden
Beyreuther, E.; Baumann, M.; Enghardt, W.; Helmbrecht, S.; Karsch, L.; Krause, M.; Pawelke, J.; Schreiner, L.; Schürer, M.; von Neubeck, C.

Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition
Klapproth, E.; Dickreuter, E.; Zakrzewski, F.; Seifert, M.; Petzold, A.; Dahl, A.; Schröck, E.; Klink, B.; Cordes, N.

Relative biological effectiveness in proton beam therapy – current knowledge and future challenges
Lühr, A.; von Neubeck, C.; Krause, M.; Troost, E. G. C.

Prognostic Value of Head and Neck Tumor Proliferative Sphericity From 3’-Deoxy-3’-[18F] Fluorothymidine Positron Emission Tomography
Majdoub, M.; Hoeben, B.; Troost, E. G. C.; Oyen, W.; Kaanders, J.; Le Rest, C.; Visser, E.; Visvikis, D.; Hatt, M.

Melanoma brain metastases: Local therapies, targeted therapies, immune checkpoint inhibitors and their combinations- chances and challenges
Kuske, M.; Rauschenberg, R.; Garzarolli, M.; Meredyth-Stewart, M.; Beissert, S.; Troost, E.; Glitza, I.; Meier, F.

Inter-centre variability of CT-based range prediction in particle therapy: Survey-based evaluation
Taasti, V.; Bäumer, C.; Dahlgren, C.; Deisher, A.; Ellerbrock, M.; Free, J.; Gora, J.; Kozera, A.; Lomax, T.; de Marzi, L.; Molinelli, S.; Teo, K.; Wohlfahrt, P.; Petersen, J.; Muren, L.; Hansen, D.; Richter, C.

Clinical feasibility of single-source dual-spiral 4D dual-energy CT for proton treatment planning within the thoracic region
Wohlfahrt, P.ORC; Troost, E. G. C.; Hofmann, C.; Richter, C.; Jakobi, A.

A comparative study of machine learning methods for time-To-event survival data for radiomics risk modelling
Leger, S.; Zwanenburg, A.; Pilz, K.; Lohaus, F.; Linge, A.; Zöphel, K.; Kotzerke, J.; Schreiber, A.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Ganswindt, U.; Belka, C.; Pigorsch, S.; Combs, S.; Mönnich, D.; Zips, D.; Krause, M.; Baumann, M.; Troost, E.; Löck, S.; Richter, C.

The EPTN consensus-based atlas for CT- and MR-based contouring in Neuro-Oncology
Eekers, D.; In 'T Ven, L.; Roelofs, E.; Postma, A.; Alapetite, C.; Burnet, N.; Calugaru, V.; Compter, I.; Coremans, I.; Hoyer, M.; Lambrecht, M.; Romero, A.; Paulsen, F.; Perpar, A.; de Ruysscher, D.; Renard, L.; Vitek, P.; Weber, D.; van der Weide, H.; Whitfield, G.; Wiggenraad, R.; Nyström, P.; Timmermann, B.; Troost, E.

Evidence on the efficacy of primary radiosurgery or stereotactic radiotherapy for drug-resistant non-neoplastic focal epilepsy in adults: a systematic review
Eekers, D.; Pijnappel, E.; Schijns, O.; Colon, A.; Hoeben, A.; Zindler, J.; Postma, A.; Hoffmann, A.; Lambin, P.; Troost, E.

The posterior cerebellum, a new organ at risk?
Eekers, D. B. P.; In 'T Ven, L.; Deprez, S.; Jacobi, L.; Roelofs, E.; Hoeben, A.; Lambin, P.; de Ruysscher, D.; Troost, E. G. C.

Photon vs. proton radiochemotherapy: effects on brain tissue volume and perfusion
Petr, J.; Platzek, I.; Hofheinz, F.; Mutsaerts, H.; Asllani, I.; van Osch, M.; Seidlitz, A.; Krukowski, P.; Gommlich, A.; Beuthien-Baumann, B.; Jentsch, C.; Maus, J.; Troost, E.; Baumann, M.; Krause, M.; van den Hoff, J.

Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging
Löck, S.; Perrin, R.; Seidlitz, A.; Bandurska-Luque, A.; Zschaeck, S.; Zöphel, K.; Krause, M.; Steinbach, J.; Kotzerke, J.; Zips, D.; Troost, E. G. C.; Baumann, M.

Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1
Francolini, G.; Thomsen, M. S.; Yates, E. S.; Kirkove, C.; Jensen, I.; Blix, E. S.; Kamby, C.; Nielsen, M. H.; Krause, M.; Berg, M.; Mjaaland, I.; Schreiber, A.; Kasti, U. M.; Boye, K.; Offersen, B. V.

Therapeutic options to overcome tumor hypoxia in radiation oncology
Troost, E.; Koi, L.; Yaromina, A.; Krause, M.

Dosimetric evidence confirms computational model of magnetic field induced dose distortions of therapeutic proton beams
Schellhammer, S. M.ORC; Gantz, S.; Lühr, A.; Oborn, B. M.; Bussmann, M.; Hoffmann, A. L.

Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy
Wijsman, R.; Dankers, F. J. W. M.; Troost, E. G. C.; Hoffmann, A. L.; van der Heijden, E. H. F. M.; de Geus-Oei, L.-F.; Bussink, J.

Experimental verification of particle-range prediction in biological tissue by single- and dual-energy computed tomography
Möhler, C.ORC; Russ, T.; Wohlfahrt, P.ORC; Elter, A.; Runz, A.; Richter, C.; Greilich, S.

Towards ion beam therapy based on laser plasma accelerators
Karsch, L.; Beyreuther, E.ORC; Enghardt, W.ORC; Gotz, M.; Masood, U.; Schramm, U.; Zeil, K.; Pawelke, J.ORC

Modeling in vivo relative biological effectiveness in particle therapy for clinically relevant endpoints
Lühr, A.; von Neubeck, C.; Helmbrecht, S.; Baumann, M.; Enghardt, W.; Krause, M.

Modeling tumor control probability for spatially inhomogeneous risk of failure based on clinical outcome data
Lühr, A.; Löck, S.; Jakobi, A.; Stützer, K.; Bandurska-Luque, A.; Vogelius, I. R.; Enghardt, W.; Baumann, M.; Krause, M.

EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: a preclinical trial in 10 HNSCC-tumour-xenograft models
Koi, L.; Löck, S.; Linge, A.; Thurow, C.; Hering, S.; Baumann, M.; Krause, M.; Gurtner, K.

Development and validation of a gene signature for patients with head and neck carcinomas treated by postoperative radio(chemo)therapy
Schmidt, S.; Linge, A.; Zwanenburg, A.; Leger, S.; Lohaus, F.; Krenn, C.; Appold, S.; Gudziol, V.; Nowak, A.; von Neubeck, C.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Bunea, H.; Grosu, A.-L.; Abdollahi, A.; Debus, J.; Ganswindt, U.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Baretton, G. B.; Buchholz, F.; Baumann, M.; Krause, M.; Löck, S.

Potential proton and photon dose degradation in advanced head and neck cancer patients by intra-therapy changes
Stützer, K.; Jakobi, A.; Bandurska-Luque, A.; Barczyk, S.; Arnsmeyer, C.; Löck, S.; Richter, C.

Dynamics of rectal balloon implant shrinkage in prostate VMAT: Influence on anorectal dose and late rectal complication risk
Vanneste, B.; van Wijk, Y.; Lutgens, L.; van Limbergen, E.; van Lin, E.; van de Beek, K.; Lambin, P.; Hoffmann, A.

Dual-energy CT based proton range prediction in head and pelvic tumor patients
Wohlfahrt, P.ORC; Möhler, C.ORC; Stützer, K.; Greilich, S.; Richter, C.

Sensitivity of a prompt-gamma slit-camera to detect range shifts for proton treatment verification
Nenoff, L.; Priegnitz, M.; Janssens, G.; Petzoldt, J.; Trezza, A.; Smeets, J.; Pausch, G.; Richter, C.

Melanoma Brain Metastases
Brütting, J.; Rauschenberg, R.; Troost, E. G. C.; Meier, F.; Garzarolli, M.

Photons, protons or carbon ions for stage I non-small cell lung cancer - results of the multicentric ROCOCO in silico study
Wink, K. C. J.; Roelofs, E.; Simone, C. B.; Dechambre, D.; Santiago, A.; van der Stoep, J.; Dries, W.; Smits, J.; Avery, S.; Ammazzalorso, F.; Jansen, N.; Jelen, U.; Solberg, T.; de Ruysscher, D.; Troost, E. G. C.

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes
Cubillos-Mesías, M.; Baumann, M.; Troost, E. G. C.; Lohaus, F.; Löck, S.; Richter, C.; Stützer, K.

Evaluation of stopping-power prediction by dual- and single-energy computed tomography in an anthropomorphic ground-truth phantom
Wohlfahrt, P.ORC; Möhler, C.ORC; Richter, C.; Greilich, S.

Proton radiography for inline treatment planning and positioning verification of small animals
Müller, J.; Neubert, C.; von Neubeck, C.; Baumann, M.; Krause, M.; Enghardt, W.; Bütof, R.; Dietrich, A.; Lühr, A.

On the equivalence of image-based dual-energy CT methods for the determination of electron density and effective atomic number in radiotherapy
Möhler, C.ORC; Wohlfahrt, P.ORC; Richter, C.; Greilich, S.

Retrospective assessment of MRI-based volumetric changes of normal tissues in glioma patients following radio(chemo)therapy
Gommlich, A.; Raschke, F.; Wahl, H.; Troost, E.ORC

Quantification of MRI visibility and artefacts at 3T of BioXmark® fiducial marker in a pancreas tissue mimicking phantom
Schneider, S.; Jølck, R. I.; Troost, E. G. C.; Hoffmann, A. L.

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy
Zschaeck, S.; Löck, S.; Leger, S.; Haase, R.; Bandurska-Luque, A.; Appold, S.; Kotzerke, J.; Zips, D.; Richter, C.; Gudziol, V.; Schreiber, A.; Zöphel, K.; Baumann, M.; Krause, M.

Targeting stem cells in radiation oncology
Coppes, R.; Dubrovska, A.

Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms
Zindler, J.; Jochems, A.; Lagerwaard, F.; Beumer, R.; Troost, E.; Eekers, D.; Compter, I.; van der Toorn, P.-P.; Essers, M.; Oei, B.

Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT
Wijsman, R.; Dankers, F.; Troost, E. G. C.; Hoffmann, A. L.; van der Heijden, E. H. F. M.; de Geus-Oei, L. F.; Bussink, J.

18F-fluorodeoxyglucose positron-emission tomography (FDG- PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) – A prospective externally validated study
Carvalho, S.; Leijenaar, R.; Troost, E.; van Timmeren, J.; Oberije, C.; van Elmpt, W.; de Geus-Oei, L.; Bussink, J.; Lambin, P.

Reduktion der adhäsions- und stress-bedingten Anpassung im Glioblastom durch beta1 integrin/JNK Doppelhemmung reduziert Radiochemoresistenz und Invasion
Vehlow, A.; Klapproth, E.; Storch, K.; Dickreuter, E.; Seifert, M.; Dietrich, A.; Bütof, R.; Temme, A.; Cordes, N.
  • Strahlentherapie und Onkologie 193(2017), S50-S51
  • Lecture (Conference)
    Jahrestagung der Deutsche Gesellschaft für Radioonkologie, 14.-18.06.2017, Berlin, Deutschland

3D matrix-based cell cultures: Automated analysis of tumor cell survival and proliferation
Eke, I.; Hehlgans, S.; Sandfort, V.; Cordes, N.

Ambidextrous Idea Generation-Antecedents and Outcomes
Gurtner, S.; Reinhardt, R.

Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
Tinhofer, I.; Budach, V.; Saki, M.; Konschak, R.; Niehr, F.; Jöhrens, K.; Weichert, W.; Linge, A.; Lohaus, F.; Krause, M.; Neumann, K.; Endris, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Baumann, M.; DKTK-ROG

A Compton camera prototype for prompt gamma medical imaging
Thirolf, P. G.; Aldawood, S.; Böhmer, M.; Bortfeldt, J.; Castelhano, I.; Dedes, G.; Fiedler, F.; Gernhäuser, R.; Golnik, C.; Helmbrecht, S.; Hueso-González, F.; von D. Kolff, H.; Kormoll, T.; Lang, C.; Liprandi, S.; Lutter, R.; Marinšek, T.; Maier, L.; Pausch, G.; Petzoldt, J.; Römer, K.; Schaart, D.; Parodi, K.

The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells
Storch, K.; Cordes, N.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1.
Offersen, B. V.; Boersma, L. J.; Kirkove, C.; Hol, S.; Aznar, M. C.; Sola, A. B.; Kirova, Y. M.; Pignol, J.-P.; Remouchamps, V.; Verhoeven, K.; Weltens, C.; Arenas, M.; Gabrys, D.; Kopek, N.; Krause, M.; Lundstedt, D.; Marinko, T.; Montero, A.; Yarnold, J.; Poortmans, P.

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
Linge, A.; Löck, S.; Krenn, C.; Appold, S.; Lohaus, F.; Nowak, A.; Gudziol, V.; Baretton, G. B.; Buchholz, F.; Baumann, M.; Krause, M.

Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter?
Lattermann, A.; Baumann, M.; Krause, M.

Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells
Dickreuter, E.; Eke, I.; Krause, M.; Borgmann, K.; van Vugt, M. A.; Cordes, N.

Bridging the valley of death: The new Radiotherapy & Oncology section “First in man - Translational innovations in radiation oncology.”
Baumann, M.; Overgaard, J.

Polyphenols delivery by polymeric materials: challenges in cancer treatment.
Vittorio, O.; Curcio, M.; Cojoc, M.; Goya, G.; Hampel, S.; Iemma, F.; Dubrovska, A.; Cirillo, G.

Nanoparticles for radiooncology: Mission, vision, challenges.
Kunz-Schughart, L.; Dubrovska, A.; Peitzsch, C.; Ewe, A.; Aigner, A.; Schellenburg, S.; Muders, M.; Hampel, S.; Cirillo, G.; Iemmae, F.; Tietze, R.; Alexiou, C.; Stephan, H.; Zarschlerg, K.; Vittorio, O.; Kavallaris, M.; Parak, W.; Mädler, L.; Pokhrel, S.

Feasibility of proton pencil beam scanning treatment of free-breathing lung cancer patients
Jakobi, A.; Perrin, R.; Knopf, A.; Richter, C.ORC

Toward Distributed Conduction of Large-Scale Studies in Radiation Therapy and Oncology: Open-Source System Integration Approach
Skripcak, T.; Just, U.; Simon, M.; Buttner, D.; Lühr, A.; Baumann, M.; Krause, M.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.
Linge, A.; Löck, S.; Gudziol, V.; Nowak, A.; Lohaus, F.; von Neubeck, C.; Jütz, M.; Abdollahi, A.; Debus, J.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Bayer, C.; Belka, C.; Pigorsch, S.; Combs, S. E.; Welz, S.; Zips, D.; Buchholz, F.; Aust, D. E.; Baretton, G. B.; Thames, H. D.; Dubrovska, A.; Alsner, J.; Overgaard, J.; Baumann, M.; Krause, M.

Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?
Wack, L. J.; Mönnich, D.; Yaromina, A.; Zips, D.; Baumann, M.; Thorwarth, D.

Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Zegers, C. M. L.; Hoebers, F. J. P.; van Elmpt, W.; Bons, J. A.; Öllers, M. C.; Troost, E. G. C.; Eekers, D.; Balmaekers, L.; Arts-Pechtold, M.; Mottaghy, F. M.; Lambin, P.

Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Jentsch, C.; Bergmann, R.; Brüchner, K.; Mosch, B.; Yaromina, A.; Krause, M.; Zips, D.; Troost, E. G. C.; Löck, S.; Kotzerke, J.; Steinbach, J.; Thames, H.; Baumann, M.; Beuthien-Baumann, B.

Pages: [All] [1] [2] [3]